FOR IMMEDIATE RELEASE | April 29, 2014
ALZHEIMER'S FOUNDATION OF AMERICA RELEASES REPORT ON CARE COSTS
NEW YORK (April 29, 2014) —In an effort to advance some of the goals in the "National Plan to Address Alzheimer's Disease," the Alzheimer's Foundation of America (AFA) today released a report that quantifies several of the plan's care delivery provisions and offers a cost-benefit analysis of their implementation. The report finds that a handful of projects will provide significant cost savings—more than $110 billion during a 10-year period—while promoting better health outcomes for individuals with Alzheimer's disease and improving quality of life for their caregivers.
Last year, a study by the RAND Corporation revealed that cost of care for a person with Alzheimer's disease was $215 billion in 2010. These costs are projected to grow to more than a trillion dollars annually by 2040 as our nation ages and the incidence of Alzheimer's disease, which currently affects more than 5 million Americans, escalates.
AFA selected several action steps in the national plan, including medical homes, coordinated care delivery, hospital safety, and effective care transitions for people with Alzheimer's disease. It enlisted respected health care economists to perform the cost analysis of these proposals as new or expanded demonstration, or model, projects or proposals that integrate into existing Medicare systems.
According to AFA's report, entitled "Cost of Care: Quantifying Care-Centered Provisions of the 'National Plan to Address Alzheimer's Disease,'" "Through limited implementation, the medical and caregiving community will demonstrate the benefits derived from redirecting services through these policy changes."
At the same time, the analysis indicates that the selected provisions would only modestly increase budget outlays, by less than $10 million during the 10-year budget period.
"Currently, costs of providing care for individuals with Alzheimer's disease are astronomical and unsustainable," said Charles J. Fuschillo, Jr., AFA's chief executive officer. "Advancing care coordination and caregiver training and supports will provide real cost savings while yielding more comprehensive care for people with Alzheimer's disease and family caregivers. Now it's time for policymakers to deliver."
The report's release coincides with a meeting today of the Advisory Council on Alzheimer's Research, Care and Services, a panel of stakeholders and federal officials charged with advising on the implementation of the national plan. Funding for the report, which is available online here, was provided by Lilly USA, LLC, and Novartis Pharmaceuticals Corporation.
# # #
About Alzheimer’s Foundation of America (AFA)
Contact: Amanda (Hirschhorn) Secor